Jonathan Kabakoff - Profile and Investment Details

Investor Profile

Jonathan Kabakoff is a Corporate Venture Capital based in San Diego, California, United States with a diverse investment portfolio that includes companies such as Molecular Assemblies, Syros Pharmaceuticals, EpiBiome, Immunitas Therapeutics, TARA Biosystems, Cydan, Kallyope, Atara BiotherapeuticsEditas Medicine, Relay Therapeutics, Molecular Assemblies, Inc., Synthego, Welldoc, Avelas Biosciences, Aura Biosciences, Yumanity Therapeutics, Lodo Therapeutics, Seres Therapeutics, Nohla Therapeutics, Vividion Therapeutics, Calimmune, Petra Pharma, Crop Enhancement, Imara, Benson Hill, Codiak Biosciences, Biological Dynamics, NextCure, Forge Therapeutics, Visterra, Inhibrx, Vtesse, Think Brilliant Media Studios, ApoGen Biotechnologies, Triplet Therapeutics, . Over time, Jonathan Kabakoff has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jonathan Kabakoff is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Cybersecurity, API, Women Founded, Enterprise Software, Chemical, Life Science, Cloud Computing, Finance, Biotechnology, Groceries, Consumer Software, Data Privacy, Agriculture, Web Development, Health Diagnostics, Regulatory Compliance, Data Management, Medical, SaaS, Information Technology, B2B, Therapeutics may find it worthwhile to explore potential connections with Jonathan Kabakoff, as their portfolio suggests a familiarity and interest in this area.

Understanding Jonathan Kabakoff’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.